vs

Side-by-side financial comparison of Silvercrest Asset Management Group Inc. (SAMG) and Sight Sciences, Inc. (SGHT). Click either name above to swap in a different company.

Silvercrest Asset Management Group Inc. is the larger business by last-quarter revenue ($32.0M vs $20.4M, roughly 1.6× Sight Sciences, Inc.). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -20.4%, a 20.0% gap on every dollar of revenue. On growth, Sight Sciences, Inc. posted the faster year-over-year revenue change (6.9% vs -0.0%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $-2.0M). Over the past eight quarters, Sight Sciences, Inc.'s revenue compounded faster (2.9% CAGR vs 2.7%).

Sight Sciences, Inc. is a commercial-stage medical technology company focused on developing and commercializing innovative products for treating common eye conditions including glaucoma and dry eye disease. It offers minimally invasive surgical devices and non-surgical care solutions, primarily serving ophthalmology clinicians and patients across the United States.

SAMG vs SGHT — Head-to-Head

Bigger by revenue
SAMG
SAMG
1.6× larger
SAMG
$32.0M
$20.4M
SGHT
Growing faster (revenue YoY)
SGHT
SGHT
+6.9% gap
SGHT
6.9%
-0.0%
SAMG
Higher net margin
SAMG
SAMG
20.0% more per $
SAMG
-0.4%
-20.4%
SGHT
More free cash flow
SAMG
SAMG
$17.0M more FCF
SAMG
$15.0M
$-2.0M
SGHT
Faster 2-yr revenue CAGR
SGHT
SGHT
Annualised
SGHT
2.9%
2.7%
SAMG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
SAMG
SAMG
SGHT
SGHT
Revenue
$32.0M
$20.4M
Net Profit
$-120.0K
$-4.2M
Gross Margin
87.3%
Operating Margin
-2.8%
-18.0%
Net Margin
-0.4%
-20.4%
Revenue YoY
-0.0%
6.9%
Net Profit YoY
-107.4%
64.9%
EPS (diluted)
$0.02
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SAMG
SAMG
SGHT
SGHT
Q4 25
$32.0M
$20.4M
Q3 25
$31.3M
$19.9M
Q2 25
$30.7M
$19.6M
Q1 25
$31.4M
$17.5M
Q4 24
$32.0M
$19.1M
Q3 24
$30.4M
$20.2M
Q2 24
$31.0M
$21.4M
Q1 24
$30.3M
$19.3M
Net Profit
SAMG
SAMG
SGHT
SGHT
Q4 25
$-120.0K
$-4.2M
Q3 25
$618.0K
$-8.2M
Q2 25
$1.9M
$-11.9M
Q1 25
$2.5M
$-14.2M
Q4 24
$1.6M
$-11.8M
Q3 24
$2.3M
$-11.1M
Q2 24
$2.7M
$-12.3M
Q1 24
$3.0M
$-16.3M
Gross Margin
SAMG
SAMG
SGHT
SGHT
Q4 25
87.3%
Q3 25
86.4%
Q2 25
84.8%
Q1 25
86.2%
Q4 24
86.8%
Q3 24
83.9%
Q2 24
85.8%
Q1 24
85.5%
Operating Margin
SAMG
SAMG
SGHT
SGHT
Q4 25
-2.8%
-18.0%
Q3 25
4.3%
-39.7%
Q2 25
13.2%
-59.6%
Q1 25
15.4%
-79.2%
Q4 24
6.1%
-62.5%
Q3 24
14.6%
-55.7%
Q2 24
17.1%
-59.2%
Q1 24
19.5%
-76.4%
Net Margin
SAMG
SAMG
SGHT
SGHT
Q4 25
-0.4%
-20.4%
Q3 25
2.0%
-41.0%
Q2 25
6.3%
-61.0%
Q1 25
7.9%
-80.8%
Q4 24
5.1%
-62.1%
Q3 24
7.4%
-54.9%
Q2 24
8.6%
-57.7%
Q1 24
9.9%
-84.4%
EPS (diluted)
SAMG
SAMG
SGHT
SGHT
Q4 25
$0.02
$-0.07
Q3 25
$0.07
$-0.16
Q2 25
$0.21
$-0.23
Q1 25
$0.26
$-0.28
Q4 24
$0.16
$-0.23
Q3 24
$0.24
$-0.22
Q2 24
$0.28
$-0.25
Q1 24
$0.32
$-0.33

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SAMG
SAMG
SGHT
SGHT
Cash + ST InvestmentsLiquidity on hand
$44.1M
$92.0M
Total DebtLower is stronger
$42.4M
Stockholders' EquityBook value
$50.3M
$63.9M
Total Assets
$166.6M
$115.3M
Debt / EquityLower = less leverage
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SAMG
SAMG
SGHT
SGHT
Q4 25
$44.1M
$92.0M
Q3 25
$36.1M
$92.4M
Q2 25
$30.0M
$101.5M
Q1 25
$36.3M
$108.8M
Q4 24
$68.6M
$120.4M
Q3 24
$58.1M
$118.6M
Q2 24
$49.9M
$118.2M
Q1 24
$39.7M
$127.3M
Total Debt
SAMG
SAMG
SGHT
SGHT
Q4 25
$42.4M
Q3 25
$42.4M
Q2 25
$42.4M
Q1 25
$42.4M
Q4 24
$40.0M
Q3 24
$37.1M
Q2 24
$35.0M
Q1 24
$35.0M
Stockholders' Equity
SAMG
SAMG
SGHT
SGHT
Q4 25
$50.3M
$63.9M
Q3 25
$58.9M
$64.3M
Q2 25
$64.6M
$70.0M
Q1 25
$80.0M
$77.6M
Q4 24
$80.7M
$87.5M
Q3 24
$84.6M
$95.0M
Q2 24
$85.3M
$101.6M
Q1 24
$83.9M
$109.2M
Total Assets
SAMG
SAMG
SGHT
SGHT
Q4 25
$166.6M
$115.3M
Q3 25
$157.6M
$116.3M
Q2 25
$152.7M
$122.0M
Q1 25
$159.9M
$129.7M
Q4 24
$194.4M
$142.8M
Q3 24
$184.2M
$143.6M
Q2 24
$177.6M
$149.7M
Q1 24
$170.2M
$155.6M
Debt / Equity
SAMG
SAMG
SGHT
SGHT
Q4 25
0.66×
Q3 25
0.66×
Q2 25
0.61×
Q1 25
0.55×
Q4 24
0.46×
Q3 24
0.39×
Q2 24
0.34×
Q1 24
0.32×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SAMG
SAMG
SGHT
SGHT
Operating Cash FlowLast quarter
$18.6M
$-1.8M
Free Cash FlowOCF − Capex
$15.0M
$-2.0M
FCF MarginFCF / Revenue
46.9%
-9.7%
Capex IntensityCapex / Revenue
11.4%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$17.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SAMG
SAMG
SGHT
SGHT
Q4 25
$18.6M
$-1.8M
Q3 25
$14.6M
$-8.7M
Q2 25
$13.8M
$-7.5M
Q1 25
$-24.7M
$-11.6M
Q4 24
$21.6M
$-3.5M
Q3 24
$13.3M
$362.0K
Q2 24
$16.0M
$-9.5M
Q1 24
$-24.1M
$-9.8M
Free Cash Flow
SAMG
SAMG
SGHT
SGHT
Q4 25
$15.0M
$-2.0M
Q3 25
$13.8M
$-8.9M
Q2 25
$13.4M
$-7.8M
Q1 25
$-25.1M
Q4 24
$19.9M
$-3.6M
Q3 24
$12.9M
$311.0K
Q2 24
$15.6M
$-9.5M
Q1 24
$-24.7M
$-9.9M
FCF Margin
SAMG
SAMG
SGHT
SGHT
Q4 25
46.9%
-9.7%
Q3 25
44.1%
-44.7%
Q2 25
43.6%
-39.6%
Q1 25
-80.0%
Q4 24
62.2%
-18.9%
Q3 24
42.4%
1.5%
Q2 24
50.4%
-44.7%
Q1 24
-81.6%
-51.4%
Capex Intensity
SAMG
SAMG
SGHT
SGHT
Q4 25
11.4%
0.8%
Q3 25
2.6%
0.9%
Q2 25
1.5%
1.1%
Q1 25
1.3%
0.0%
Q4 24
5.3%
0.7%
Q3 24
1.2%
0.3%
Q2 24
1.1%
0.4%
Q1 24
2.0%
0.6%
Cash Conversion
SAMG
SAMG
SGHT
SGHT
Q4 25
Q3 25
23.62×
Q2 25
7.22×
Q1 25
-10.01×
Q4 24
13.34×
Q3 24
5.90×
Q2 24
6.00×
Q1 24
-8.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SAMG
SAMG

Investment Advisory Management And Administrative Service$30.7M96%
Tax And Family Office Services$1.2M4%

SGHT
SGHT

Surgical Glaucoma$19.7M96%
Other$724.0K4%

Related Comparisons